PMID- 14673567 OWN - NLM STAT- MEDLINE DCOM- 20041122 LR - 20181113 IS - 0033-3158 (Print) IS - 0033-3158 (Linking) VI - 173 IP - 3-4 DP - 2004 May TI - DNA damage and ubiquitinated neuronal inclusions in the substantia nigra and striatum of mice following MDMA (ecstasy). PG - 353-63 AB - RATIONALE: 3,4-Methylenedioxymethamphetamine (MDMA) is an amphetamine derivative, which is neurotoxic to both serotonin (5HT) and dopamine (DA) nerve terminals. Previous reports, carried out in rodents and non-human primates, demonstrated neurotoxicity to monoamine axon terminals, although no study has analyzed nigral and striatal cell bodies at the sub-cellular level. OBJECTIVE: In this study, we examined intrinsic nigral and striatal cells, and PC12 cell cultures to evaluate whether, in mice, MDMA might affect nigral and striatal cell bodies. METHODS: After administering MDMA, we analyzed effects induced in vivo and in vitro using high-performance liquid chromatography (HPLC) analysis, light- and electron microscopy with immunocytochemistry, and DNA comet assay. RESULTS: We found that MDMA (5 mg/kg x4, 2 h apart), besides a decrease of nigrostriatal DA innervation and 5HT loss, produces neuronal inclusions within nigral and intrinsic striatal neurons consisting of multi-layer ubiquitin-positive whorls extending to the nucleus of the cell. These fine morphological changes are associated with clustering of heat shock protein (HSP)-70 in the nucleus, very close to chromatin filaments. In the same experimental conditions, we could detect oxidation of DNA bases followed by DNA damage. The nature of inclusions was further investigated using PC12 cell cultures. CONCLUSIONS: The present findings lead to re-consideration of the neurotoxic consequences of MDMA administration. In fact, occurrence of ubiquitin-positive neuronal inclusions and DNA damage both in nigral and striatal cells sheds new light into the fine alterations induced by MDMA, also suggesting the involvement of nuclear and cytoplasmic components of the ubiquitin-proteasome pathway in MDMA toxicity. FAU - Fornai, F AU - Fornai F AD - Department of Human Morphology and Applied Biology, University of Pisa, 56126 Pisa, Italy. f.fornai@med.unipi.it FAU - Lenzi, P AU - Lenzi P FAU - Frenzilli, G AU - Frenzilli G FAU - Gesi, M AU - Gesi M FAU - Ferrucci, M AU - Ferrucci M FAU - Lazzeri, G AU - Lazzeri G FAU - Biagioni, F AU - Biagioni F FAU - Nigro, M AU - Nigro M FAU - Falleni, A AU - Falleni A FAU - Giusiani, M AU - Giusiani M FAU - Pellegrini, A AU - Pellegrini A FAU - Blandini, F AU - Blandini F FAU - Ruggieri, S AU - Ruggieri S FAU - Paparelli, A AU - Paparelli A LA - eng PT - Journal Article DEP - 20031213 PL - Germany TA - Psychopharmacology (Berl) JT - Psychopharmacology JID - 7608025 RN - 0 (Serotonin Agents) RN - 0 (Ubiquitin) RN - KE1SEN21RM (N-Methyl-3,4-methylenedioxyamphetamine) RN - VTD58H1Z2X (Dopamine) SB - IM MH - Animals MH - Corpus Striatum/*drug effects/metabolism/pathology MH - *DNA Damage MH - Dopamine/metabolism MH - Male MH - Mice MH - Mice, Inbred C57BL MH - N-Methyl-3,4-methylenedioxyamphetamine/*toxicity MH - Neurons/*metabolism/ultrastructure MH - PC12 Cells MH - Rats MH - Serotonin Agents/*toxicity MH - Substantia Nigra/*drug effects/metabolism/pathology MH - Ubiquitin/*metabolism EDAT- 2003/12/16 05:00 MHDA- 2004/12/16 09:00 CRDT- 2003/12/16 05:00 PHST- 2003/08/26 00:00 [received] PHST- 2003/11/04 00:00 [accepted] PHST- 2003/12/16 05:00 [pubmed] PHST- 2004/12/16 09:00 [medline] PHST- 2003/12/16 05:00 [entrez] AID - 10.1007/s00213-003-1708-3 [doi] PST - ppublish SO - Psychopharmacology (Berl). 2004 May;173(3-4):353-63. doi: 10.1007/s00213-003-1708-3. Epub 2003 Dec 13.